Addition of Etoricoxib During Concurrent Chemo-radiation of Cervical Cancer Patients Could Result in Faster Resolution of Gross Disease: A Prospective Single-Institution Study-Reference-Cited by-同舟云学术

Addition of Etoricoxib During Concurrent Chemo-radiation of Cervical Cancer Patients Could Result in Faster Resolution of Gross Disease: A Prospective Single-Institution Study

Published:2019-11-15 Issue:1 Volume:18 Page:
ISSN:2363-8397
Container-title:Indian Journal of Gynecologic Oncology
language:en
Short-container-title:Indian J Gynecol Oncolog

Author:

Dhar Sovan Sarang,Shahi Uday Pratap,Kumar Deepak,Mishra Ritusha,Kaser Prashant,Dewangan Satish,Mandal Abhijit,Choudhary Sunil,Aggarwal Lalit Mohan,Asthana Anupam Kumar,Pradhan Satyajit

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s40944-019-0331-0.pdf

Reference23 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):1–31.

2. Dutta S, Biswas N, Muhkherjee G. Evaluation of socio-demographic factors for non-compliance to treatment in locally advanced cases of cancer cervix in a rural medical college hospital in India. Indian J Palliat Care. 2013;19(3):158–65.

3. Doll CM, Winter K, Gaffney DK, et al. COX-2 expression and survival in patients with locally advanced treated with chemoradiotherapy and celecoxib: a quantitative immunohistochemical analysis of RTOG C0128. Int J Gynecol Cancer. 2013;23(1):176–83.

4. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781–6.

5. Jung YW, Lee SH, Paek JH, et al. Acute toxicity of cyclooxygenase-2 inhibitor rofecoxib as a radiosensitizer for concurrent chemoradiation in the treatment of uterine cervical cancer. J Gynecol Oncol. 2009;20(3):151–7.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer;International Journal of Molecular Sciences;2024-06-01

2. Effect of ABO blood group on postoperative overall survival and recurrence-free survival rate in patients with hepatocellular carcinoma after hepatectomy: a multi-center retrospective cohort study;BMC Surgery;2023-10-24

3. Diagnostic Accuracy of Intraoperative Frozen Section in Ovarian Neoplasms: A Tertiary Cancer Center Experience;Indian Journal of Gynecologic Oncology;2023-09-09

4. Being sick to a cancer patient: pathways of delay in help seeking and diagnosis of cancer in India;Journal of Social and Economic Development;2022-11-22

5. Understanding local community customers: Perspectives from place attachment and customer satiation;Advances in Psychological Science;2022-07-01